Rajat Mehta - 05 Sep 2025 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO BIO.B)

Role
EVP, GBL Commercial Operations
Signature
/s/ Rajat Mehta
Issuer symbol
BIO BIO.B
Transactions as of
05 Sep 2025
Transactions value $
$0
Form type
4
Filing time
09 Sep 2025, 16:19:12 UTC
Previous filing
14 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mehta Rajat EVP, GBL Commercial Operations C/O BIO-RAD LABORATORIES, INC., 1000 ALFRED NOBEL DR, HERCULES /s/ Rajat Mehta 09 Sep 2025 0002081681

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO BIO.B Restricted Stock Units Award $0 +1.83K $0.00 1.83K 05 Sep 2025 Bio-Rad A Common Stock 1.83K $0.00 Direct F1, F2
transaction BIO BIO.B Restricted Stock Units Award $0 +5.48K $0.00 5.48K 05 Sep 2025 Bio-Rad A Common Stock 5.48K $0.00 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F2 On September 5, 2025, the reporting person was granted 1,827 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F3 The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.